Dublin, Dec. 05, 2019 (GLOBE NEWSWIRE) -- The "Global Precision Medicine Partnering 2014-2019: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

The Global Precision Medicine Partnering 2014-2019 report provides comprehensive understanding and unprecedented access to the Precision medicine partnering deals and agreements entered into by the worlds leading healthcare companies.

This report provides details of the latest Precision Medicine agreements announced in the life sciences since 2014.

The report takes the reader through a comprehensive review Precision Medicine deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Precision Medicine partnering deals.

The report presents financial deal term values for Precision Medicine deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Precision Medicine partnering field; both the leading deal values and most active Precision Medicine dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 900 online deal records of actual Precision Medicine deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

A comprehensive series of appendices is provided organized by Precision Medicine partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Precision Medicine partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Precision Medicine technologies and products.

Key Benefits

• In-depth understanding of Precision Medicine deal trends since 2014
• Access to headline, upfront, milestone and royalty data
• Analysis of the structure of Precision Medicine agreements with numerous real life case studies
• Detailed access to actual Precision Medicine contracts entered into by leading biopharma companies
• Identify most active Precision Medicine dealmakers since 2014
• Insight into terms included in a Precision Medicine partnering agreement, with real world examples
• Understand the key deal terms companies have agreed in previous deals
• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report Scope

Precision Medicine Partnering Terms and Agreements includes:

• Trends in Precision Medicine dealmaking in the biopharma industry since 2014
• Analysis of Precision Medicine deal structure
• Access to headline, upfront, milestone and royalty data
• Case studies of real-life Precision Medicine deals
• Access to Precision Medicine contract documents
• Leading Precision Medicine deals by value since 2014
• Most active Precision Medicine dealmakers since 2014

Available deals are listed by:

• Company A-Z
• Headline value
• Stage of development at signing
• Deal component type
• Specific therapy target
• Technology type
  

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Precision Medicine dealmaking
2.1. Introduction
2.2. Precision Medicine partnering over the years
2.3. Most active Precision Medicine dealmakers
2.4. Precision Medicine partnering by deal type
2.5. Precision Medicine partnering by therapy area
2.6. Deal terms for Precision Medicine partnering
2.6.1 Precision Medicine partnering headline values
2.6.2 Precision Medicine deal upfront payments
2.6.3 Precision Medicine deal milestone payments
2.6.4 Precision Medicine royalty rates

Chapter 3 - Leading Precision Medicine deals
3.1. Introduction
3.2. Top Precision Medicine deals by value

Chapter 4 - Most active Precision Medicine dealmakers
4.1. Introduction
4.2. Most active Precision Medicine dealmakers
4.3. Most active Precision Medicine partnering company profiles

Chapter 5 - Precision Medicine contracts dealmaking directory
5.1. Introduction
5.2. Precision Medicine contracts dealmaking directory

Chapter 6 - Precision Medicine dealmaking by technology type

Chapter 7 - Partnering resource center
7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices

Appendix 1 - Precision Medicine deals by company A-Z

Appendix 2 - Precision Medicine deals by stage of development

• Discovery
• Preclinical
• Phase I
• Phase II
• Phase III
• Regulatory
• Marketed
• Formulation

Appendix 3 - Precision Medicine deals by deal type

• Asset purchase
• Assignment
• Bigpharma outlicensing
• Co-development
• Collaborative R&D
• Co-market
• Co-promotion
• CRADA
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Settlement
• Spin out
• Sub-license
• Supply
• Technology transfer
• Termination

Appendix 4 - Precision Medicine deals by therapy area

Appendix 5 - Deal type definitions

For more information about this report visit https://www.researchandmarkets.com/r/kbd1ou

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900